Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC RegisterM.H. Otten, Lisette W. A. van Suijlekom‐Smit, Y. Koopman-Keemink et al.|Annals of the Rheumatic Diseases|2012Cited by 59
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children RegisterM.H. Otten, Lisette W. A. van Suijlekom‐Smit, Janneke Anink et al.|Annals of the Rheumatic Diseases|2014Cited by 58
Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children RegisterJanneke Anink, Lisette W. A. van Suijlekom‐Smit, M.H. Otten et al.|Lara D. Veeken|2012Cited by 20